Rethinking Alzheimer’s at the cellular level
Aerobyx is developing a new approach to Alzheimer’s focused on how brain cells produce and use energy.
The Challenge
A Different Approach
What We’re Building
Alzheimer’s disease affects millions worldwide, yet available treatments don’t stop its progression. For decades, research has focused on amyloid plaques and tau tangles with limited success.
Emerging research suggests Alzheimer’s may begin with disruptions in how brain cells generate energy. Aerobyx is focused on mitochondrial function and neuronal metabolism, processes that may play a role early in disease development.
Aerobyx is developing a bioenergetic therapy designed to support cellular energy function in the brain. This approach aims to address underlying disease mechanisms rather than focusing solely on symptoms.
Why It Matters
Targets a potential root cause of disease
Builds on established scientific research
